Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD)

与白人和非裔美国人种族差异相关的食物过敏结果(转发)

基本信息

  • 批准号:
    9922208
  • 负责人:
  • 金额:
    $ 91.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-05-11 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Background: Food allergy (FA) is a potentially life-threatening condition that affects an estimated 8% of children in the United States. Although differences between African American (AA) and White children in the prevalence and severity of other atopic conditions such as asthma and eczema have been well described, little is known about such differences in FA. The limited existing literature indicates that AA children may have worse clinical outcomes, including rates of FA-related fatal anaphylaxis and FA-related emergency department (ED) visits, than their White peers. Phenotypic and endotypic differences, including rates of sensitization and co-morbidities, between AA and White children are beginning to be examined. Data on racial differences in FA management practices are incomplete; preliminary data suggest that AA families spend significantly less on allergen-free foods and FA medications than do White families. Families caring for children with FA experience significant impairments in psychosocial outcomes, including FA-related quality of life (FAQoL); however, these data come primarily from White, privately insured families, and little is known about psychosocial outcomes in AA families. Two recent reviews concluded that existing studies examining racial disparities in FA are far too methodologically limited to draw definitive conclusions, primarily due to reliance on self-report of FA diagnosis and cross-sectional designs. Specific Aims and Methods: Our goal is to prospectively study a cohort of 600 AA and White children (0-12 years) with FA in order to: 1) Determine variability in clinical FA outcomes between AA and White patients via bimonthly remote assessments, biannual clinic visits, and medical chart review over a two-year period; 2) Examine phenotypic and endotypic differences between AA and White children with FA using specific laboratory specimen collection techniques and assays; 3) Identify differences between AA and White children in FA management practices by parent report (e.g. allergen avoidance and epinephrine carriage); and 4) Determine differences between AA and White children in psychosocial FA-related outcomes (e.g., FA-related quality of life, bullying, anxiety, and worry) via the above survey methods. Hypotheses and Expected Results: We hypothesize that compared to White children, AA children will: have higher rates of food-allergic reactions and FA-related healthcare utilization; demonstrate unique FA phenotypes and endotypes; have poorer knowledge of FA management and worse adherence to preventative behaviors; have limited access to medications and allergen-free foods; and report better quality of life. Significance and Effects on Other Research: Confirming and further characterizing differences between AA and White children with FA will provide the data required to develop clinical guidelines, optimize treatment, and build health policies that meet the needs of both AA and White children.
项目总结/摘要 背景:食物过敏(FA)是一种潜在的危及生命的疾病, 在美国的孩子们。虽然非洲裔美国人(AA)和白色儿童在 其他特应性疾病如哮喘和湿疹的患病率和严重程度已得到很好的描述, 已知FA中的这种差异。有限的现有文献表明,AA儿童可能有 更差的临床结局,包括FA相关致死性速发型过敏反应和FA相关急诊的发生率 (ED)访问,比他们的白色同龄人。表型和内型差异,包括致敏率和 AA和白色儿童之间的共病开始被检查。FA的种族差异数据 管理实践是不完整的;初步数据表明,AA家庭花费显着减少, 不含过敏原的食物和FA药物的比例要比白色家庭高。照顾有FA经验儿童的家庭 心理社会结局的显著损害,包括FA相关生活质量(FAQoL);然而,这些 数据主要来自白色、私人保险家庭,人们对黑人的心理社会结果知之甚少 AA家庭最近的两篇综述得出结论,现有的研究在FA中的种族差异太大了。 在方法学上受限于得出明确结论,主要是由于依赖于FA诊断的自我报告 和横截面设计。 具体目的和方法:我们的目标是前瞻性研究600名AA和白色儿童(0-12岁 年),以便:1)确定AA和白色患者之间临床FA结局的变异性 通过两个月一次的远程评估、一年两次的诊所访问和两年期间的病历审查; 2) 使用特异性抗体检测AA和白色FA儿童之间的表型和内型差异。 实验室标本采集技术和分析; 3)识别AA和白色之间的差异 按家长报告的FA管理实践中的儿童(例如,避免过敏原和携带肾上腺素); 和4)确定AA和白色儿童在心理社会FA相关结果方面的差异 (e.g., FA相关的生活质量,欺负,焦虑和担心)通过上述调查方法。 假设和预期结果:我们假设与白色儿童相比,AA儿童将: 食物过敏反应和FA相关医疗保健利用率较高;证明FA独特 表型和内型; FA管理知识较差,预防性治疗依从性较差 行为;获得药物和无过敏原食物的机会有限;并报告更好的生活质量。 对其他研究的意义和影响:确认和进一步表征差异 AA和白色FA儿童之间的差异将提供制定临床指南所需的数据, 优化治疗,并建立满足AA和白色儿童需求的卫生政策。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ruchi S Gupta其他文献

Ruchi S Gupta的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ruchi S Gupta', 18)}}的其他基金

FORWARD-COVID 19 Supplement
FORWARD-COVID 19 补充资料
  • 批准号:
    10189267
  • 财政年份:
    2020
  • 资助金额:
    $ 91.2万
  • 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
  • 批准号:
    10212208
  • 财政年份:
    2019
  • 资助金额:
    $ 91.2万
  • 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
  • 批准号:
    10425291
  • 财政年份:
    2019
  • 资助金额:
    $ 91.2万
  • 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
  • 批准号:
    10666514
  • 财政年份:
    2019
  • 资助金额:
    $ 91.2万
  • 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
  • 批准号:
    9982763
  • 财政年份:
    2019
  • 资助金额:
    $ 91.2万
  • 项目类别:
Food Allergy Management and Outcomes Related to Racial/Ethnic Differences from Infancy through Adolescence: The FORWARD Study
食物过敏管理和与从婴儿期到青春期的种族/民族差异相关的结果:FORWARD 研究
  • 批准号:
    10446840
  • 财政年份:
    2017
  • 资助金额:
    $ 91.2万
  • 项目类别:
Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD)
与白人和非裔美国人种族差异相关的食物过敏结果(转发)
  • 批准号:
    9398764
  • 财政年份:
    2017
  • 资助金额:
    $ 91.2万
  • 项目类别:
Food Allergy Management and Outcomes Related to Racial/Ethnic Differences from Infancy through Adolescence: The FORWARD Study
食物过敏管理和与从婴儿期到青春期的种族/民族差异相关的结果:FORWARD 研究
  • 批准号:
    10580069
  • 财政年份:
    2017
  • 资助金额:
    $ 91.2万
  • 项目类别:
FORWARD Supplement: Common Data Elements for Food Allergy
FORWARD 补充:食物过敏的通用数据元素
  • 批准号:
    10868981
  • 财政年份:
    2017
  • 资助金额:
    $ 91.2万
  • 项目类别:
Improving Food Allergy Management through an Electronic Physician Support Tool
通过电子医生支持工具改善食物过敏管理
  • 批准号:
    8584033
  • 财政年份:
    2013
  • 资助金额:
    $ 91.2万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 91.2万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 91.2万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 91.2万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 91.2万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 91.2万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 91.2万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 91.2万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 91.2万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 91.2万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 91.2万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了